Harbin Gloria Pharmaceuticals Co. Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 3,054.949 million compared to CNY 5,053.859 million a year ago. Operating income was CNY 579.117 million compared to operating loss of CNY 2,472.547 million a year ago. Net income was CNY 400.049 million compared to net loss of CNY 2,661.773 million a year ago. Basic earnings per share from continuing operations was CNY 0.182 compared to basic loss per share from continuing operations of CNY 1.2109 a year ago.